Your session is about to expire
← Back to Search
Trifluridine/Tipiracil for Colorectal Cancer (SUNLIGHT Trial)
SUNLIGHT Trial Summary
This trial will compare the efficacy and safety of a combination of drugs versus one of the drugs alone in patients with a certain type of cancer that has not responded to other treatments.
- Colorectal Cancer
SUNLIGHT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSUNLIGHT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2023 Phase 3 trial • 492 Patients • NCT04737187SUNLIGHT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have other important medical problems.You have another type of cancer.You can swallow pills.
- Group 1: Trifluridine/Tipiracil
- Group 2: Trifluridine/Tipiracil + Bevacizumab
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is Trifluridine/Tipiracil a new or experimental medication?
"As of right now, 411 clinical trials are underway for Trifluridine/Tipiracil. Of these active studies, 103 have progressed to Phase 3 testing. The large majority of the related studies are based in Taibei, Taiwan but there are 19423 locations worldwide running similar investigations."
What are the most common indications for Trifluridine/Tipiracil?
"Trifluridine/Tipiracil, which is commonly used to treat recurrent platinum-resistant epithelial ovarian cancer, can also be useful for treating other conditions such as previously treated with oxaliplatin chemotherapy, malignant neoplasms, and recurrent platinum sensitive primary peritoneal cancer."
How many people can safely participate in this experiment?
"This clinical trial is not presently seeking patients at this time. The trial was first posted on 11/25/2020 and was last edited on 4/4/2022. If you are exploring for other studies, there are presently 896 clinical trials actively admitting patients with colorectal cancer and 411 studies for Trifluridine/Tipiracil actively recruiting patients."
What is the FDA's opinion on Trifluridine/Tipiracil?
"Trifluridine/Tipiracil has been studied in Phase 3 trials, which means that while there is evidence of efficacy, more data is needed to support safety."
Are there any current openings for patients who want to participate in this research?
"This study, which was most recently updated on April 4th, 2022 is not currently looking for new participants. This according to the data available on clinicaltrials.gov. Out of the 1,307 other trials that are recruiting patients at this time, this one is not."
Share this study with friends
Copy Link
Messenger